Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biobehavioral Mechanisms Underlying Improving Sleep to Reduce Risk for Substance Use Disorder

NCT03226132 is registered in ClinicalTrials.gov with Florida State University as lead sponsor.

NCT NCT03226132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biobehavioral Mechanisms Underlying Improving Sleep to Reduce Risk for Substance Use Disorder
Lead sponsor
Florida State University
Phase
Not applicable
Overall status
Completed
Start date
August 20, 2017
Completion date
September 1, 2018
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, posttraumatic stress disorder, substance use disorders